Genzyme reborn as Sanofi-Genzyme Korea
A pharmaceutical company specializing in rare diseases, Genzyme has been re-born as a Sanofi Group’s ‘Sanofi Genzyme’ department.
According to the industry concerned on the 19th, the Sanofi’s Korean branch confirmed the business reorganization, combined anticancer products and Genzyme products, ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
